Prevalence of Hypermobile Ehlers-Danlos Syndrome in Transgender and Gender Diverse Individuals: A Retrospective Cohort Study
LGBT Health · 01.01.2026 · 13 (1) · 32-38
DOI: 10.1177/23258292251382250 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift LGBT Health, online erschienen am 23.01.2026. Verfasst von Tomasz Tabernacki und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Ehlers-Danlos Syndrome, Transgender Persons, Joint Instability. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Case Western Reserve University Clinical and Translational Science Collaborative.
Abstract (Originalsprache)
Purpose
This study compared the prevalence of hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorder (HSD) between transgender and gender-diverse (TGD) individuals and cisgender individuals.
Methods
We conducted a retrospective analysis using a large electronic health record database spanning 2004–2024. TGD individuals were identified using International Classification of Diseases, Tenth Revision codes related to gender identity and stratified by hormone therapy status. Cisgender comparison groups were defined by the absence of gender identity diagnoses and hormone therapy exposure. Prevalence odds ratios (ORs) with 95% confidence intervals were calculated to compare hEDS and HSD diagnoses between groups.
Results
TGD individuals demonstrated a significantly higher prevalence of hEDS and HSD than cisgender individuals (OR: 18.45). The prevalence among TGD individuals assigned female at birth was 2.62%, and among those assigned male at birth, 1.00%, compared with 0.16% and 0.04% in cisgender females and males, respectively. Hormone therapy status was not associated with significant differences in prevalence.
Conclusions
These findings indicate a substantially increased burden of hypermobility-related disorders among TGD individuals. Enhanced clinical recognition and multidisciplinary management strategies are needed to address the unique health care challenges faced by this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
- Urology Institute, University Hospitals, Cleveland, Ohio, USA.
- St. Bonaventure University, New York, USA.
- Department of Urology, MetroHealth Cleveland Medical Center, Cleveland, Ohio, USA.
- Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.
ORCID-Profile: Tomasz Tabernacki, Matthew Loria
Förderung
- Case Western Reserve University Clinical and Translational Science Collaborative
Zitieren
APA
Tabernacki, T., McLachlan, L., Loria, M., Gupta, S., Banik, S., Mishra, K., & McNamara, M. (2026). Prevalence of Hypermobile Ehlers-Danlos Syndrome in Transgender and Gender Diverse Individuals: A Retrospective Cohort Study. LGBT Health, 13(1), 32-38. https://doi.org/10.1177/23258292251382250
Vancouver
Tabernacki T, McLachlan L, Loria M, Gupta S, Banik S, Mishra K, et al. Prevalence of Hypermobile Ehlers-Danlos Syndrome in Transgender and Gender Diverse Individuals: A Retrospective Cohort Study. LGBT Health. 2026;13(1):32-38. doi:10.1177/23258292251382250
BibTeX
@article{Tabernacki2026,
author = {Tabernacki, Tomasz and McLachlan, Lydia and Loria, Matthew and Gupta, Shubham and Banik, Swagata and Mishra, Kirtishri and McNamara, Megan},
title = {Prevalence of Hypermobile Ehlers-Danlos Syndrome in Transgender and Gender Diverse Individuals: A Retrospective Cohort Study},
journal = {LGBT Health},
year = {2026},
volume = {13},
number = {1},
pages = {32--38},
doi = {10.1177/23258292251382250}
}
EUVIMED